When used for weight management, these medications pump the brakes on our appetites and the rate at which food exits the stomach
GLP-1/GIP Medications: A New Tool for Weight Loss GLP-1/GIP receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro,Zepbound) are FDA-approved medications originally developed to treat type 2 diabetesbut now also used for weight loss
ID8 Trp53 / model of ovarian cancer For the ovarian cancer experiments, C57BL/6J female mice (67 weeks old) were purchased from Charles River Laboratories UK (RRID: IMSR_JAX:000664) and allowed to acclimatize for at least 1 week before any regulated procedures were performed
Researchers followed people who had prediabetes and overweight or obesity for three years
Subsequent studies further revealed that both TNF- and LPS activate the c-Jun N-terminal kinase (JNK) pathway to phosphorylate IRS-1 at Ser307, which blocks PI3K/Akt signaling and consequently impairs glucose uptake (45)
Left uncontrolled, however, it can cause serious problems